FDA Import Refusal AEK-0593779-1/10002/1 — NATRAPHARM INCORPORATED
The FDA refused shipment AEK-0593779-1/10002/1 from NATRAPHARM INCORPORATED (Philippines) on May 26, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75
Refusal Details
- Date
- May 26, 2026
- Country
- Philippines
- Product Category
- Drugs and Biologics
- Product Code
- 61JDY08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
- Charges
- 75